BIRC5 and neoplasm: Although survivin gene downregulation and inhibitor agents demonstrate apoptosis-promoting and cell cycle regulatory effects favoring a negative tumor microenvironment, the efficacy of survivin inhibition in combination with the current standard Stupp protocol is critical in determining the clinical translation of such complex molecular interplay.